BASSETTI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 25.071
AS - Asia 6.328
EU - Europa 4.953
SA - Sud America 1.103
AF - Africa 106
Continente sconosciuto - Info sul continente non disponibili 28
OC - Oceania 6
Totale 37.595
Nazione #
US - Stati Uniti d'America 24.935
SG - Singapore 2.824
CN - Cina 1.496
UA - Ucraina 1.368
BR - Brasile 919
IT - Italia 846
HK - Hong Kong 783
DE - Germania 710
SE - Svezia 651
TR - Turchia 479
VN - Vietnam 386
RU - Federazione Russa 362
IE - Irlanda 272
FI - Finlandia 215
GB - Regno Unito 188
IN - India 99
AR - Argentina 80
NL - Olanda 66
CA - Canada 55
MX - Messico 55
FR - Francia 48
AT - Austria 46
BD - Bangladesh 38
PL - Polonia 36
BE - Belgio 34
EC - Ecuador 29
ZA - Sudafrica 29
EU - Europa 25
JP - Giappone 23
KR - Corea 23
IQ - Iraq 21
CZ - Repubblica Ceca 20
ES - Italia 20
ID - Indonesia 19
CO - Colombia 18
UZ - Uzbekistan 17
CL - Cile 16
MA - Marocco 16
PK - Pakistan 16
PE - Perù 15
RS - Serbia 12
SA - Arabia Saudita 12
AE - Emirati Arabi Uniti 11
PY - Paraguay 11
AZ - Azerbaigian 9
IR - Iran 9
PH - Filippine 9
DO - Repubblica Dominicana 8
LT - Lituania 8
CH - Svizzera 7
KE - Kenya 7
NP - Nepal 7
TN - Tunisia 7
VE - Venezuela 7
BO - Bolivia 6
DK - Danimarca 6
HU - Ungheria 6
IL - Israele 6
JO - Giordania 6
LV - Lettonia 6
AO - Angola 5
GH - Ghana 5
RO - Romania 5
BG - Bulgaria 4
DZ - Algeria 4
ET - Etiopia 4
KG - Kirghizistan 4
LB - Libano 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
AM - Armenia 3
EG - Egitto 3
KZ - Kazakistan 3
LK - Sri Lanka 3
NG - Nigeria 3
OM - Oman 3
PA - Panama 3
AU - Australia 2
BH - Bahrain 2
BW - Botswana 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
LU - Lussemburgo 2
MM - Myanmar 2
MY - Malesia 2
MZ - Mozambico 2
NO - Norvegia 2
SN - Senegal 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BJ - Benin 1
BN - Brunei Darussalam 1
BS - Bahamas 1
Totale 37.560
Città #
Fairfield 3.666
Woodbridge 3.348
Houston 2.251
Ann Arbor 1.932
Ashburn 1.890
Seattle 1.468
Chandler 1.364
Wilmington 1.309
Cambridge 1.302
Singapore 1.039
Dearborn 815
Hong Kong 776
Beijing 726
Jacksonville 686
Izmir 453
Boardman 431
Princeton 299
Dublin 269
Udine 190
San Diego 175
Los Angeles 172
Des Moines 163
Dong Ket 158
Dallas 127
Redondo Beach 118
Buffalo 108
Falls Church 94
Ho Chi Minh City 84
São Paulo 79
Milan 78
Andover 74
Hefei 68
Norwalk 64
Munich 63
New York 59
Nanjing 55
Hanoi 51
Ogden 51
Guangzhou 40
Kunming 40
Phoenix 37
Brussels 34
Rome 33
Nuremberg 32
Redmond 32
Shanghai 32
Warsaw 32
Grafing 30
Rio de Janeiro 30
Jinan 28
Fuzhou 26
Trieste 26
Frankfurt am Main 24
London 23
Vienna 22
Chicago 21
Santa Clara 21
Belo Horizonte 20
Fremont 20
Johannesburg 20
Tokyo 20
Turin 20
Bologna 19
Chennai 19
Council Bluffs 19
Mumbai 19
Mexico City 18
Redwood City 18
Stockholm 18
Brooklyn 17
Montreal 17
Nanchang 17
Venezia 17
Zhengzhou 17
Atlanta 16
Brno 16
Curitiba 16
Naples 16
Brasília 15
Denver 15
Wuhan 15
Boston 14
Buenos Aires 14
Helsinki 14
Toronto 14
Washington 14
Da Nang 13
Haiphong 13
Maserada Sul Piave 13
Hanover 12
Hebei 12
Ottawa 12
Poplar 12
Porto Alegre 12
Quito 12
Tashkent 12
Düsseldorf 11
Goiânia 11
Lauterbourg 11
San Francisco 11
Totale 27.279
Nome #
Terapia e profilassi delle infezioni 341
A regional approach to Antimicrobial Stewardship: the Friuli Venezia Giulia program 252
Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: An individual participant data meta-analysis 245
Exploring ecological modelling to investigate factors governing the colonization success in nosocomial environment of Candida albicans and other pathogenic yeasts 232
Antibiotic-resistant Pseudomonas aeruginosa: Focus on care in patients receiving assisted ventilation 229
The management of multidrug-resistant enterobacteriaceae 223
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 220
Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae? 211
Delafloxacin for the treatment of respiratory and skin infections 207
Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant 191
Adherence to international and national recommendations for the prevention of surgical site infections in Italy: Results from an observational prospective study in elective surgery 182
Management of reduced vaccine coverage due to 6 years of failure to vaccinate: The Codroipo case, Italy 181
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 180
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. 179
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 179
"Excess mortality" and colistin-tigecycline for extensively drug-resistant Acinetobacter baumannii bacteremia 175
Ceftolozane/tazobactam for the treatment of serious P. aeruginosa infections: a multicenter nationwide clinical experience 171
Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15) 168
Task force on management and prevention of Acinetobacter baumannii infections in the ICU 168
Hot topics in necrotising skin and soft tissue infections 168
Gitelman syndrome disclosed by calcium pyrophosphate deposition disease: Early diagnosis by ultrasonographic study 167
Antibiotic stewardship challenges in the management of community-acquired infections for prevention of escalating antibiotic resistance 167
Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamaseproducing Enterobacteriaceae in haematological patients with neutropaenia: A study protocol for a retrospective observational study (BICAR) 167
Advances in antibiotic therapy in the critically ill 165
New therapeutic options for respiratory tract infections 163
Antiretroviral blood levels in HIV/HCV-coinfected patients with cirrhosis after liver transplant: A report of three cases 162
Current and future treatment options for infections caused by multidrug-resistant Gram-negative pathogens 162
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure 162
Variable incidence of candidemia in patients admitted to ICUs or medical wards of large tertiary-care Italian hospitals 160
Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections 160
Serological and T Cell Responses after Varicella Zoster Virus Vaccination in HIV-Positive Patients Undergoing Renal Dialysis 160
DALI: Defining antibiotic levels in intensive care unit patients: Are current ß-lactam antibiotic doses sufficient for critically ill patients? 159
Safety of long-term use of linezolid: Results of an open-label study 159
Year in review in Intensive Care Medicine 2013: II. Sedation, invasive and noninvasive ventilation, airways, ARDS, ECMO, family satisfaction, end-of-life care, organ donation, informed consent, safety, hematological issues in critically ill patients 159
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality 159
Focus on optimization of early antimicrobial therapy in ICU-acquired infections 158
Association between source control and mortality in 258 patients with intra-abdominal candidiasis: a retrospective multi-centric analysis comparing intensive care versus surgical wards in Spain 158
Characteristics of an ideal nebulized antibiotic for the treatment of pneumonia in the intubated patient 157
Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update 157
18F-Fluorodeoxyglucose positron emission tomography and infectious diseases: current applications and future perspectives 157
Current and future therapies for invasive aspergillosis 156
Is first-line antimicrobial therapy still adequate to treat MRSA in the ICU? A report from a highly endemic country 156
Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: A critical agenda 156
Anidulafungin for the treatment of candidaemia caused by Candida parapsilosis: Analysis of pooled data from six prospective clinical studies 156
An Italian consensus for invasive candidiasis management (ITALIC) 156
Persistent viremia and urine shedding of tick-borne encephalitis virus in an infected immunosuppressed patient from a new epidemic cluster in North-Eastern Italy 155
Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients 155
Community-acquired Legionella Pneumonia in the intensive care unit: Impact on survival of combined antibiotic therapy 155
The role of dalbavancin in skin and soft tissue infections 155
Ceftolozane/tazobactam: place in therapy 155
First report of endocarditis by Gluconobacter spp. in a patient with a history of intravenous-drug abuse 154
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort 154
Resistance mechanisms and epidemiology of multiresistant pathogens in europe and efficacy of tigecycline in observational studies 154
New therapeutic options for skin and soft tissue infections 154
Impact of new treatment options for hepatitis c virus infection in liver transplantation 154
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement 154
Focus on antimicrobial use in the era of increasing antimicrobial resistance in ICU 153
Tick-borne encephalitis in North-East Italy: A 14-year retrospective study, January 2000 to December 2013 153
Year in review in Intensive Care Medicine 2013: III. Sepsis, infections, respiratory diseases, pediatrics 152
Linezolid underexposure in a patient co-treated with venlafaxine 151
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study-authors' response 151
Recurrent seizures during acute acquired toxoplasmosis in an immunocompetent traveller returning from Africa 151
The role of methicillin-resistant Staphylococcus aureus in skin and soft tissue infections 151
Epidemiology, species distribution, antifungal susceptibility, and outcome of Candidemia across five sites in Italy and Spain 151
Different miRNA expression in transplanted livers of HCV mono-infected and HCV/HIV co-infected recipients 151
Linezolid underexposure in a hypothyroid patient on levothyroxine replacement therapy: A case report 151
Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics 148
Global survey on nebulization of antimicrobial agents in mechanically ventilated patients: A call for international guidelines 148
Development of novel antibacterial drugs to combat multiple resistant organisms 148
A survey on infection management practices in Italian ICUs 148
Prosthetic joints: Shining lights on challenging blind spots 147
How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae? 147
Diagnosis and management of invasive candidiasis in the ICU: An updated approach to an old enemy 147
Is empiric daptomycin effective in reducing mortality in Staphylococcus aureus bacteraemia? A real-life experience 146
Critically ill migrants with infection: diagnostic considerations for intensive care physicians in Europe 146
Predictive models for identification of hospitalized patients harboring KPC-producing klebsiella pneumoniae 146
Infezioni delle vie urinarie: appropriatezza in antibioticoterapia 145
Efficacy of tigecycline for the treatment of complicated intraabdominal infections in real-life clinical practice from five european observational studies 145
Intratracheal administration of antimicrobial agents in mechanically ventilated adults: An international survey on delivery practices and safety 145
Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: Lessons from the DALI Study 145
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 144
Treatment of Candida Infections with Fluconazole in Adult Liver Transplant Recipients: Is TDM-guided Dosing Adaptation Helpful? 144
Immunological profiles of HIV-positive recipients of liver transplant 144
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 143
Infective endocarditis in elderly: An Italian prospective multi-center observational study 143
Designing a pathogen-focused study to address the high unmet medical need represented by carbapenem-resistant gram-negative pathogens – the international, multicenter, randomized, open-label, phase 3 credible-cr study 143
Are prophylactic antifungals in highly colonized patients safe and effective? 143
Epidemiology and predictors of recurrence of Clostridium difficile infection in a North Italian tertiary care hospital 142
Is there a future for tigecycline? 142
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 142
Fungal endogenous endophthalmitis secondary to magnusiomyces capitatus 142
MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for management 142
Efficacy of intravenous cyclosporine in a case of cytophagic histiocytic panniculitis complicated by haemophagocytic syndrome after visceral leishmania infection 142
SDD and colistin resistance: End of a dream? 141
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: A meta-analysis of individual participant data 141
Determination of PCT on admission is a useful tool for the assessment of disease severity in travelers with imported Plasmodium falciparum malaria 141
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 141
Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study 141
Patient specific risk stratification for antimicrobial resistance and possible treatment strategies in gram-negative bacterial infections 141
New antibiotics and antimicrobial combination therapy for the treatment of gram-negative bacterial infections 140
Totale 16.207
Categoria #
all - tutte 131.405
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 131.405


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.241 0 0 0 0 0 663 329 524 523 246 474 482
2021/20222.808 175 220 223 157 55 197 219 104 49 443 502 464
2022/20233.147 340 150 42 411 353 902 1 230 524 35 77 82
2023/2024829 160 103 40 22 188 73 33 42 84 34 14 36
2024/20254.553 137 357 226 220 138 259 221 354 565 405 457 1.214
2025/20264.501 646 908 680 665 1.424 178 0 0 0 0 0 0
Totale 38.825